These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12768940)

  • 1. Homocysteine and the vascular endothelium.
    Jacobs P; Wood L
    S Afr Med J; 2003 Mar; 93(3):191-2. PubMed ID: 12768940
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of hyperhomocysteine-induced endothelial dysfunction in rats.
    Korokin MV; Pokrovskiy MV; Novikov OO; Gudyrev OS; Gureev VV; Denisyuk TA; Korokina LV; Danilenko LM; Ragulina VA; Konovalova EA; Belous AS
    Bull Exp Biol Med; 2011 Dec; 152(2):213-5. PubMed ID: 22808463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
    Woo KS; Sanderson JE; Sun YY; Chook P; Cheung AS; Chan LT; Metreweli C; Lolin YI; Celermajer DS
    Circulation; 2000 Mar; 101(12):E116. PubMed ID: 10736298
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of thrombosis in hyperhomocysteinemia.
    Lentz SR
    Curr Opin Hematol; 1998 Sep; 5(5):343-9. PubMed ID: 9776214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key references: Homocysteine and atherothrombotic vascular disease.
    Loscalzo J
    J Thromb Thrombolysis; 2000 Jan; 9(1):125-6. PubMed ID: 10590207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperhomocysteinemia--a new risk factor for vascular diseases?].
    Brattström L; Israelsson B; Hultberg B
    Lakartidningen; 1992 Feb; 89(7):467-9. PubMed ID: 1738269
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperhomocysteinaemia and endothelial dysfunction in dialysis patients: what should be treated first?
    Righetti M
    Nephrol Dial Transplant; 2008 Mar; 23(3):1069; author reply 1069-71. PubMed ID: 17951310
    [No Abstract]   [Full Text] [Related]  

  • 10. Homocysteine in occlusive vascular disease: a risk marker or risk factor.
    Bhargava S; Ali A; Manocha A; Kankra M; Das S; Srivastava LM
    Indian J Biochem Biophys; 2012 Dec; 49(6):414-20. PubMed ID: 23350275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor.
    Fijnheer R; Blann AD
    J Rheumatol; 2003 Jul; 30(7):1400-2. PubMed ID: 12858432
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
    Moat SJ; Bonham JR; Powers HJ
    Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic mild hyperhomocysteinemia induces aortic endothelial dysfunction but does not elevate arterial pressure in rats.
    Miao CY; Villeneuve N; Brunel-Jacquemin C; Petit C; Guillaumin JP; Gransagne D; Briant C; Vilaine JP; Vanhoutte PM
    J Vasc Res; 2005; 42(2):148-56. PubMed ID: 15713986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
    Dayal S; Lentz SR
    Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
    De Vriese AS; Blom HJ; Heil SG; Mortier S; Kluijtmans LA; Van de Voorde J; Lameire NH
    Circulation; 2004 May; 109(19):2331-6. PubMed ID: 15117854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.